| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765330A1 Lactam inhibitors of cholesterol esterase |
| 04/02/1997 | EP0765328A1 Pirydyl imidazole derivatives and processes for the preparation thereof |
| 04/02/1997 | EP0765327A1 Pyrazolo and pyrrolopyridines |
| 04/02/1997 | EP0765326A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 04/02/1997 | EP0765322A1 Indole derivatives as prodrugs of 5-ht 1?-like receptor agonists |
| 04/02/1997 | EP0765320A1 Benzimidazolone derivatives with central dopaminergic activity |
| 04/02/1997 | EP0765314A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 04/02/1997 | EP0765311A1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines |
| 04/02/1997 | EP0765308A1 Enzyme inhibitors |
| 04/02/1997 | EP0765305A1 Anti-inflammatory compounds |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0765152A1 Stimulation of hair growth by peptide-copper complexes |
| 04/02/1997 | EP0739335A4 Pyrrolidine-containing monomers and oligomers |
| 04/02/1997 | EP0680323B1 Synergising association having an antagonist effect on nk1 and nk2 receptors |
| 04/02/1997 | EP0670735B1 Peripheralization of hematopoietic stem cells |
| 04/02/1997 | EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 04/01/1997 | US5616705 Useful in the control of diseases |
| 04/01/1997 | US5616620 Amino acid derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of obesity |
| 04/01/1997 | US5616614 Useful in treatment of disorders linked to abnormal melatonin activity |
| 04/01/1997 | US5616612 Therapy for cancer, aids, anemia, infections |
| 04/01/1997 | US5616601 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
| 04/01/1997 | US5616596 Substituted arylalkynyl-and heteroarylalkynl-N-hydroxyurea inhibitors of leukotriene biosynthesis |
| 04/01/1997 | US5616586 Tricyclic quinoxalinediones |
| 04/01/1997 | US5616574 Steroid sulphatase inhibitors |
| 04/01/1997 | US5616571 Aftertreatment for side effect reduction |
| 04/01/1997 | US5616560 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| 04/01/1997 | US5616556 Method of treating rheumatoid arthritis and osteoarthrosis using tetrahydro WS9326A |
| 03/29/1997 | CA2186717A1 Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products |
| 03/28/1997 | CA2186580A1 Substituted benzoylguanidines, a process for their preparation, their use as medicament or diagnostic agent, and medicament comprising them |
| 03/27/1997 | WO1997011178A1 Human growth hormone variants |
| 03/27/1997 | WO1997011079A1 Novel imidazole lipoxygenase inhibitors |
| 03/27/1997 | WO1997011069A1 Heterocyclic compounds as bradykinin antagonists |
| 03/27/1997 | WO1997011056A1 Indole derivatives as melatoninergic analogues |
| 03/27/1997 | WO1997010840A1 Anti-inflammatory antisense drug |
| 03/27/1997 | WO1997010825A1 SELECTIVE β3 ADRENERGIC AGONISTS |
| 03/27/1997 | WO1997010824A1 Use of 5ht1b receptor antagonist for the treatment of vascular disease |
| 03/27/1997 | WO1997010806A1 Aerosol compositions |
| 03/27/1997 | WO1997010712A1 Inhibition of tumor necrosis factor alpha |
| 03/27/1997 | WO1997005859A3 Use of alicyclic diamines as immunomodulators |
| 03/27/1997 | WO1997002051A3 Cascade polymer complexes |
| 03/27/1997 | WO1997001636A3 Recombinant mistletoe lectin |
| 03/27/1997 | WO1997001344A3 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 03/27/1997 | WO1996040728A3 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/27/1997 | CA2658039A1 Human growth hormone variants |
| 03/27/1997 | CA2232434A1 Selective .beta.3 adrenergic agonists |
| 03/26/1997 | EP0764659A1 Use of cyclodextrins and their derivatives for solubilising compounds of the Ginkgolide family |
| 03/26/1997 | EP0764645A1 Novel 3,4-diaryl furans and analogs thereof having use as anti-inflammatory agents |
| 03/26/1997 | EP0764644A1 Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a gastrointestinal condition |
| 03/26/1997 | EP0764640A1 Selective beta3 adrenergic agonists |
| 03/26/1997 | EP0764443A1 Ameliorant or remedy for paraneoplastic syndrome |
| 03/26/1997 | EP0764208A1 Bmp-9 compositions |
| 03/26/1997 | EP0764167A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme |
| 03/26/1997 | EP0764153A1 Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity |
| 03/26/1997 | EP0764152A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 03/26/1997 | EP0764149A1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 03/26/1997 | EP0764027A1 Method for protection against genotoxic mutagenesis |
| 03/26/1997 | EP0759292B1 Use of alpha type melanocytes stimulating hormone derivatives to stimulate the hairgrowth |
| 03/26/1997 | EP0680470B1 Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 03/26/1997 | EP0642531B1 Monomer and dimer peptides, utilization as cytoprotector agents and preparation method |
| 03/26/1997 | EP0639077B1 Drug for increasing the level of testosterone in the body |
| 03/26/1997 | EP0559751B1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 03/26/1997 | EP0539493B1 Targeted drug delivery via phosphonate derivatives |
| 03/26/1997 | CN1146207A Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/26/1997 | CN1146201A Sulphonamide derivatives as aspartyl protease inhibitors |
| 03/26/1997 | CN1146153A Use of ginsenoside Ro or plant extract containing same to promote collagen synthesis |
| 03/26/1997 | CN1146152A Use of bisphophonates for inhibiting bone resorption following |
| 03/26/1997 | CN1145896A New alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 03/26/1997 | CN1145895A New amido-ethyl substituted fluorene compound and its prepn. |
| 03/26/1997 | CN1145894A New arylalkyl (thio) carboxamides, processes for preparing them and pharmacetuical compositions containing them |
| 03/26/1997 | CN1145799A 消鼾口服液 Eliminate snoring oral |
| 03/26/1997 | CN1145783A Pharmaceutical composition |
| 03/26/1997 | CN1145781A Kappa-opiate agonists for inflammatory bowel disorders |
| 03/25/1997 | US5614649 Treatment of muscular disorders, substituted guanidines |
| 03/25/1997 | US5614628 Antitumor |
| 03/25/1997 | US5614625 Collagenase inhibitors |
| 03/25/1997 | US5614555 Amidinophenol derivatives |
| 03/25/1997 | US5614551 Inhibitors of fatty acid synthesis as antimicrobial agents |
| 03/25/1997 | US5614550 Anticholesterol agents or arteriosclerosis agents for humans |
| 03/25/1997 | US5614547 Small molecule inhibitors of rotamase enzyme |
| 03/25/1997 | US5614541 Pharmacologically active catechol derivatives |
| 03/25/1997 | US5614540 Compounds useful for treating allergic and inflammatory diseases |
| 03/25/1997 | US5614537 Enzyme inhibitors of proline hydroxylase for inhibition of collagen biosynthesis and deposition |
| 03/25/1997 | US5614535 Adhesion receptor antagonists |
| 03/25/1997 | US5614526 Use of phenoxy-piperzine derivatives |
| 03/25/1997 | US5614521 Nerve growth factor |
| 03/25/1997 | US5614515 Preventing tissue adhesion after surgery |
| 03/25/1997 | US5614513 Release agent binder for vitamin d compounds and derivatives |
| 03/25/1997 | US5614496 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1997 | US5614488 Cytoxic fragment of a peptide toxin |
| 03/25/1997 | US5614213 Use of estriol for treatment of climacteric osteoporosis |
| 03/25/1997 | US5614199 Inclusion complexes of clavulanic acid and of alkali salts thereof with hydrophilic and hydrophobic β-cyclodextrin derivatives, a process for the preparation thereof and the use thereof |
| 03/25/1997 | US5614189 Recombinantly produced lipases for therapeutical treatment |
| 03/25/1997 | CA1339007C Collagen wound healing matrices and process for their production |
| 03/20/1997 | WO1997010361A1 Method for modulating cell apoptosis |
| 03/20/1997 | WO1997010257A1 Phenylsubstituted 4-azasteroid fluoroderivatives |
| 03/20/1997 | WO1997010238A1 Quinolein-2(1h)-one derivatives as serotonin antagonists |
| 03/20/1997 | WO1997010236A1 Esters of non-steroidal anti-inflammatory carboxylic acids |
| 03/20/1997 | WO1997010230A1 Diarylalkenylamine derivatives |